Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 2 of 2 results for olipudase alfa

  1. Olipudase alfa for treating acid sphingomyelinase deficiency (Niemann–Pick disease) type AB and type B (HST32)

    Evidence-based recommendations on olipudase alfa (Xenpozyme) for treating acid sphingomyelinase deficiency (Niemann–Pick disease) in people with type AB or type B.

    Highly specialised technologies guidance
    Published
    2 April 2025
    View recommendations

    Sections for HST32

  2. Past appeals and decisions

    Past technology appraisal appeals and decisions